Filing Details
- Accession Number:
- 0000950170-24-110485
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-30 19:12:50
- Reporting Period:
- 2024-09-27
- Accepted Time:
- 2024-09-30 19:12:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590750 | Viridian Therapeutics Inc. | VRDN | Services-Medical Laboratories (8071) | 471187261 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741382 | W. Thomas Beetham | C/O Viridian Therapeutics, Inc. 221 Crescent Street, Suite 103A Waltham MA 02453 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-27 | 5,000 | $23.41 | 6,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 1,000 shares acquired under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan (the "ESPP") on September 19, 2024 in transactions that were exempt under Rule 16b-3(c).
Billionaire Hedge Funds
